274 related articles for article (PubMed ID: 15931701)
21. Survival on chronic dialysis: 10 years' experience of a single Colombian center.
Enríquez J; Bastidas M; Mosquera M; Ceballos O; Bastidas B; Argote E; Salazar J; Delgado M
Adv Perit Dial; 2005; 21():164-7. PubMed ID: 16686311
[TBL] [Abstract][Full Text] [Related]
22. [Study of immutable variables determining rHuEPO dose requirements on hemodialysis patients].
Gascón A; Virto R; Lou LM; Pernaute R; Moreno R; Pérez J; Aladrén MJ; Moragrega B; Castillón E; Gómez R; Vives PJ; Alvarez R; García FJ; Castilla J; Gutiérrez Colón JA
Nefrologia; 2005; 25(5):535-42. PubMed ID: 16392304
[TBL] [Abstract][Full Text] [Related]
23. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
Attallah N; Osman-Malik Y; Frinak S; Besarab A
Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and severity of anemia in pediatric hemodialysis patients.
Azhir A; Nasiri J; Gheisari A
Saudi Med J; 2007 Feb; 28(2):249-53. PubMed ID: 17268705
[TBL] [Abstract][Full Text] [Related]
25. Nutritional profile and inflammatory status of stable chronic hemodialysis patients at Nephrology Department, Military Hospital Rawalpindi.
Siddiqui UA; Halim A; Hussain T
J Ayub Med Coll Abbottabad; 2007; 19(4):29-31. PubMed ID: 18693592
[TBL] [Abstract][Full Text] [Related]
26. Dyslipidemia and anemia in chronically hemodialyzed patients.
Malik J; Svobodová J; Tuka V; Mokrejsová M; Tesar V
Prague Med Rep; 2007; 108(2):177-84. PubMed ID: 18225644
[TBL] [Abstract][Full Text] [Related]
27. Chlamydia pneumoniae infection and ischemic heart disease in hemodialysis patients.
Wszola M; Kwiatkowski A; Nosek R; Podsiadly E; Meszaros J; Danielewicz R; Lisik W; Ostrowski K; Chmura A; Adadyński L; Paczek L; Durlik M; Tylewska-Wierzbanowska S; Rowiński W
Transplant Proc; 2006; 38(1):31-4. PubMed ID: 16504656
[TBL] [Abstract][Full Text] [Related]
28. Effects of monthly dose and regular dosing of intravenous active vitamin D use on mortality among patients undergoing hemodialysis.
St Peter WL; Li S; Liu J; Gilbertson DT; Arneson TJ; Collins AJ
Pharmacotherapy; 2009 Feb; 29(2):154-64. PubMed ID: 19170585
[TBL] [Abstract][Full Text] [Related]
29. What influences the level of oxidative stress as measured by 8-hydroxy-2'-deoxyguanosine in patients on hemodialysis?
Mastalerz-Migas A; Steciwko A; Pokorski M; Pirogowicz I; Drobnik J; Bunio A; Muszyńska A; Jasińska A
J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():199-205. PubMed ID: 17072047
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular manifestations in chronic renal failure patients on hemodialysis.
Al-Ezzy YA; Al-Barraq AO; Al-Hamaty NA; Haza'a K; Thania SY; Al-Saidy FA
Saudi Med J; 2003 Jun; 24(6):652-5. PubMed ID: 12847597
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of chronic renal failure by means of routine hemodialysis].
Tanchev I; Genov Kh; Kurlova E; Stavreva E; Tancheva D
Vutr Boles; 1982; 21(3):53-61. PubMed ID: 7113186
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary hypertension and predisposing factors in patients receiving hemodialysis.
Mousavi SA; Mahdavi-Mazdeh M; Yahyazadeh H; Azadi M; Rahimzadeh N; Yoosefnejad H; Ataiipoor Y
Iran J Kidney Dis; 2008 Jan; 2(1):29-33. PubMed ID: 19367006
[TBL] [Abstract][Full Text] [Related]
33. Adequacy of hemodialysis in Nepalese patients undergoing maintenance hemodialysis.
Sultania P; Acharya PS; Sharma SK
JNMA J Nepal Med Assoc; 2009; 48(173):10-3. PubMed ID: 19529051
[TBL] [Abstract][Full Text] [Related]
34. Elevated homocysteine levels in patients with end-stage renal disease.
Nair AP; Nemirovsky D; Kim M; Geer EB; Farkouh ME; Winston J; Halperin JL; Robbins MJ
Mt Sinai J Med; 2005 Nov; 72(6):365-73. PubMed ID: 16358160
[TBL] [Abstract][Full Text] [Related]
35. [Left ventricular hypertrophy in patients on hemodialysis: importance of anemia].
Stojimirović B; Petrović D; Obrenović R
Med Pregl; 2007; 60 Suppl 2():155-9. PubMed ID: 18928184
[TBL] [Abstract][Full Text] [Related]
36. Staff-assisted nursing home haemodialysis: patient characteristics and outcomes.
Reddy NC; Korbet SM; Wozniak JA; Floramo SL; Lewis EJ
Nephrol Dial Transplant; 2007 May; 22(5):1399-406. PubMed ID: 17259652
[TBL] [Abstract][Full Text] [Related]
37. The influence of serum 25-hydroxy vitamin D levels on Helicobacter Pylori Infections in patients with end-stage renal failure on regular hemodialysis.
Nasri H; Baradaran A
Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):215-9. PubMed ID: 17496397
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
39. Endotoxemia in chronic renal failure.
Nisbeth U; Hällgren R; Eriksson O; Danielson BG
Nephron; 1987; 45(2):93-7. PubMed ID: 3550501
[TBL] [Abstract][Full Text] [Related]
40. Serum leptin levels and malnutrition in patients with chronic renal failure.
Kayardi M; Icagasioglu S; Yilmaz A; Candan F
Saudi Med J; 2006 Apr; 27(4):477-81. PubMed ID: 16598323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
